A study to assess whether maintenance treatment with esomeprazole 20mg od is at least as effective as lansoprazole 30mg od in patients with reflux disease - A 3 month, randomised, double blind, double dummy, multicenter study

Study identifier:D9612L00011

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A study to assess whether maintenance treatment with esomeprazole 20mg od is at least as effective as lansoprazole 30mg od in patients with reflux disease - A 3 month, randomised, double blind, double dummy, multicenter study

Medical condition

gastrointestinal diseases

Phase

Phase 4

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Sept 2003
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria